Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.930 +0.080 (+2.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 1,001,191
Open 3.890
Bid (Size) 3.800 (1,000)
Ask (Size) 3.970 (141,200)
Prev. Close 3.850
Today's Range 3.850 - 3.960
52wk Range 1.665 - 6.050
Shares Outstanding 112,280,375
Dividend Yield N/A

Performance

YTD
+15.6%
+15.6%
1 Month
+5.4%
+5.4%
3 Month
+23.2%
+23.2%
6 Month
+44.0%
+44.0%
1 Year
-19.0%
-19.0%

More News

Read More

Frequently Asked Questions

Is Maravai LifeSciences Holdings, Inc. - Class A common stock publicly traded?
Yes, Maravai LifeSciences Holdings, Inc. - Class A common stock is publicly traded.
What exchange does Maravai LifeSciences Holdings, Inc. - Class A common stock trade on?
Maravai LifeSciences Holdings, Inc. - Class A common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock?
The ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock is MRVI on the Nasdaq Stock Market
What is the current price of Maravai LifeSciences Holdings, Inc. - Class A common stock?
The current price of Maravai LifeSciences Holdings, Inc. - Class A common stock is 3.930
When was Maravai LifeSciences Holdings, Inc. - Class A common stock last traded?
The last trade of Maravai LifeSciences Holdings, Inc. - Class A common stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock?
The market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock is 441.26M
How many shares of Maravai LifeSciences Holdings, Inc. - Class A common stock are outstanding?
Maravai LifeSciences Holdings, Inc. - Class A common stock has 441M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article